Skip to main content
. 2019 Apr 17;17:68. doi: 10.1186/s12955-019-1129-6

Table 2.

EQ-5D-5 L dimensions, index and VAS scores and SF-12 domains, composite scores and SF-6D; overall and by presence of arthritis

Overall (N = 2844)
Mean ± SD, or N(%)
Without Arthritis
(N = 1802)
Mean ± SD, or N(%)
With Arthritis (N = 1042)
Mean ± SD, or N(%)
Mobility
 level 1 1957 (68.8) 1429 (79.3) 528 (50.7)
 level 2 582 (20.5) 262 (14.5) 320 (30.7)
 levels 3, 4, 5 305 (10.7) 111 (6.2) 194 (18.6)
Self-care
 level 1 2718 (95.6) 1751 (97.2) 967 (92.8)
 level 2 79 (2.8) 28 (1.6) 51 (4.9)
 level 3, 4, 5 47 (1.6) 23 (1.3) 24 (2.3)
Usual Activities
 level 1 2104 (74.0) 1486 (82.5) 618 (59.3)
 level 2 532 (18.7) 230 (12.8) 302 (29.0)
 level 3, 4, 5 208 (7.3) 86 (4.8) 122 (11.7)
Pain/Discomfort
 level 1 848 (29.8) 710 (39.4) 138 (13.2)
 level 2 1557 (54.8) 926 (51.4) 631 (60.6)
 level 3, 4, 5 439 (15.4) 166 (9.2) 273 (26.2)
Anxiety/ Depression
 level 1 2046 (71.9) 1343 (74.5) 703 (67.5)
 level 2 667 (23.5) 397 (22.1) 270 (25.9)
 level 3, 4, 5 131 (4.6) 62 (3.4) 69 (6.6)
Difference Effect size
EQ-5D-5 LIndex score 0.86 ± 0.11 0.88 ± 0.09 0.83 ± 0.13 0.05 0.5
EQ-VAS 81.9 ± 14.1 83.3 ± 13.8 79.5 ± 14.3 3.8 0.3
PF 49.7 ± 9.2 51.2 ± 8.4 47.0 ± 9.9 4.2 0.5
RP 48.8 ± 8.9 50.3 ± 8.4 46.2 ± 9.0 4.1 0.5
BP 49.4 ± 8.7 51.4 ± 7.7 46.1 ± 9.1 5.3 0.6
GH 52.6 ± 8.2 53.6 ± 8.0 50.9 ± 8.3 2.6 0.3
VT 52.7 ± 7.7 53.8 ± 7.4 50.9 ± 8.0 2.9 0.4
SF 51.7 ± 7.9 52.7 ± 7.1 50.1 ± 8.9 2.5 0.3
RE 49.9 ± 9.2 50.8 ± 8.6 48.4 ± 10.1 2.3 0.3
MH 53.7 ± 7.4 50.3 ± 7.1 52.7 ± 7.7 1.6 0.2
SF-6D 0.79 ± 0.13 0.81 ± 0.12 0.75 ± 1.3 0.06 0.5
PCS 49.7 ± 8.4 51.3 ± 7.7 46.9 ± 8.7 4.4 0.5
MCS 52.8 ± 7.0 53.7 ± 6.5 51.3 ± 7.5 2.4 0.3

All differences were statistically significant at P < 0.001